MissionIR Articles

Northwest Biotherapeutics, Inc. is a development-stage biotechnology company engaging in the discovery, development and commercialization of immunotherapy products for treating cancers. The company’s DCVax uses activated dendritic cells to mobilize a patient’s own immune system…

Amarantus BioScience Holdings, Inc. is a development-stage biotechnology company focusing on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases. The company is developing the Mesencephalic-Astrocyte-derived Neurotrophic…

DS Healthcare Group, Inc. develops and markets hair, skin, health and personal care products. The company’s products include the Revita shampoo and Revita.Cor conditioner for hair growth stimulation; Spectral.DNC spray formula, Spectral.DNC-L lotion, and Spectral…

Synergy Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing drugs for treating gastrointestinal (GI) disorders and diseases. Synergy’s lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist which has completed Phase…

Prima BioMed Ltd. is a biotechnology company researching and developing licensed medical biotechnology products in Australia. The company’s lead product is CVac, a cancer vaccine for patients in remission, which has completed two human clinical…

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on the discovery, acquisition, development and commercialization of proprietary therapeutics that target cancer stem cells (CSCs) and tumor bulk. In addition to developing StemScreen platform technology…

Rosetta Genomics Ltd. develops diagnostic tools for microRNAs, a group of genes produced using instructions encoded in DNA. The company offers diagnostic tests, including miRview mets2, a microRNA-based diagnostic used to identify 42 tumor types…

AtheroNova Inc. is a development stage company engaging in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. The company develops intellectual property that uses certain pharmacological compounds for the…

Opexa Therapeutics, Inc. is a biopharmaceutical company that develops personalized cellular therapies to treat multiple sclerosis (MS) using its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in…

OHR Pharmaceutical, Inc. is a biotechnology company. The company’s products include Squalamine, an anti-angiogenic small molecule with a novel intracellular mechanism that inhibits vascular endothelial, platelet derived and basic fibroblast growth factors to treat the…

PharmAthene, Inc. is a biodefense company developing medical countermeasures against biological and chemical threats. The company’s product candidates include: SparVax, an anthrax vaccine which has completed a Phase II clinical trial for post-exposure prophylaxis; Valortim,…

Mast Therapeutics, Inc. (NYSE: MSTX) is a biopharmaceutical company developing therapies for life-threatening diseases. The company’s lead product candidate is MST-188, which has hemorheologic, cytoprotective, and anti-inflammatory properties and is in phase 3 study for…

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company developing prescription drugs targeting rare neuromuscular and neurological diseases and disorders. The company’s principal product is Firdapse, which is in Phase III clinical trial for the…